|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Program of the 3rd International Workshop on
|
||
| Saturday, October 9, 2004 | Hilton Paris | |
|
8:00-9:00 |
Breakfast |
|
| Session V: Autoimmune related disorders in WM | ||
| Chair: Dr. Stone (USA) and Dr. Brouet (France) | ||
|
9:00 AM |
Dr. Stone (USA) |
|
|
9:15 AM |
Dr. Fermand (France) |
|
|
9:30 AM |
Dr. Poulain (France) |
(FcgR)IIIA and IIA polymorphisms in WM and autoimmune disorders |
|
9:45 AM |
Dr. Levine (USA) |
|
|
10:00 AM |
Dr. Gertz (USA) |
|
|
10:15-10:30 |
Dr. Brouet (France) |
Wrap-Up and Discussion |
|
10:30-10:45 |
Session Break |
Refreshments |
|
||
| Session VI: Prognostic Markers in Waldenström's macroglobuilinemia | ||
| Co-Chairs: Drs. Merlini (Italy) and Morel (France) | ||
|
10:45 AM |
Dr. Merlini (Italy) |
|
|
11:15 AM |
Dr. Ghobrial (USA)* |
|
|
11:30 AM |
Dr. Anagnostopoulos* (Greece) |
Prognostic value of b2 microglobulin in WM patients requiring treatment |
|
11:45-12:15 |
Dr. Morel (France) |
Wrap-Up and Discussion |
|
|
||
|
12:00-1:30 |
Session Break |
Lunch |
|
|
||
|
|
||
| Session VII Therapeutics in WM: Update on nucleoside analogue trials | ||
| Chair: Drs. LeBlond (France) and Weber (USA) | ||
|
1:30 PM |
Dr. Johnson (UK) |
Phase III trial of chlorambucil vs. fludarabine as initial therapy in WM |
|
1:45 PM |
Dr. LeBlond (France) |
|
|
2:00 PM |
Dr. Tam (Australia)* |
Fludarabine combination therapy as frontline and salvage therapy in WM |
|
2:15 PM |
Dr. Treon (USA) |
|
|
2:30 PM |
Dr. Hensel (Germany) |
|
|
2:45-3:15 |
Dr. Barlogie (USA) |
Special Lecture:Do nucleoside analogues really compromise autologous stem cell transplants? |
|
3:15-3:30 |
Dr. LeBlond (France) |
Wrap-Up and Panel Discussion |
|
3:30-3:45 |
Session Break |
Refreshments |
|
|
||
| Session VIII Monoclonal antibody therapy-Predictive factors and observations | ||
| Chair: Dr. Dimopoulos (Greece) | ||
|
3:45 PM |
Dr. Dimopoulos (Greece) |
|
|
4:00 PM |
Dr. Hatjiharissi (Greece) |
|
|
4:15 PM |
Dr. Gertz (USA) |
|
|
4:30 PM |
A. Branagan (USA) |
|
|
4:45-5:00 |
Dr. Dimopoulos |
Wrap-Up and Discussion |
|
|
||
| Session IX Therapeutics in WM: Update on monoclonal antibody trials | ||
| Chair: Drs. Kimby (Sweden) and Maloney (USA) | ||
|
5:00 PM |
Z. Hunter (USA) |
|
|
5:15 PM |
Dr. Treon (USA) |
|
|
5:30 PM |
Dr. Owen (UK) |
|
|
5:45 PM |
Dr. Santos (Brazil)* |
|
|
6:00-6:15 |
Dr. Kimby (Sweden) |
Wrap-Up and Panel Discussion |
|
|
||
|
7:30 PM |
Buses depart for dinner reception |
|
|
|
||
| << Friday, October 8 | Sunday, October 10 >> | ||
|
*Young Investigator Award Recipient; Sponsored by the International Waldenstrom's Macroglobulinemia Foundation. | ||